Palo Alto, CA, United States of America

Craig S Gibbs

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Gilead Sciences, Inc.. Active years: 2000-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig S Gibbs. Retrieved from https://idiyas.com/inventor/craig-s-gibbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 126(Granted Patents)


Location History:

  • San Francisco, CA (US) (2000 - 2006)
  • Palo Alto, CA (US) (2008 - 2010)

Company Filing History:


Years Active: 2000-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Mind of Craig S Gibbs: Pioneering Therapeutic Solutions in Palo Alto

Introduction: Craig S Gibbs, a prolific inventor based in Palo Alto, CA, is making waves in the field of pharmaceuticals with his groundbreaking patented inventions. With four patents to his name, Gibbs is a driving force behind the development of therapeutic phosphonate and anti-inflammatory compounds. Currently employed at Gilead Sciences, Inc., Gibbs showcases a relentless dedication to pushing the boundaries of medical science.

Latest Patents: Gibbs' latest patents include the development of therapeutic phosphonate compounds. These phosphorus-substituted agents open new doors for therapeutic methods and compositions that promise innovative treatment approaches. Additionally, his work on anti-inflammatory phosphonate compounds underscores his commitment to advancing pharmaceutical solutions for various medical conditions.

Career Highlights: Gibbs' career highlights exemplify his sustained commitment to innovation in the pharmaceutical sector. His patent portfolio reflects a deep understanding of complex therapeutic agents and their potential applications. By focusing on phosphorus substitution, Gibbs has carved out a unique niche in developing novel pharmaceutical compounds that hold promise for improving patient outcomes.

Collaborations: Gibbs collaborates closely with esteemed colleagues at Gilead Sciences, Inc., including Carina E Cannizzaro and James Ming Chen. This collaborative spirit underscores his team-oriented approach to innovation, where diverse perspectives converge to drive cutting-edge research and development efforts forward.

Conclusion: In conclusion, Craig S Gibbs stands as a beacon of innovation in Palo Alto, CA, redefining the landscape of therapeutic solutions through his patented inventions. With a proven track record of success and a collaborative mindset, Gibbs is poised to continue reshaping the future of pharmaceuticals with his pioneering work at Gilead Sciences, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…